Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Major response to everolimus in melanoma with acquired imatinib resistance.

Major response to everolimus in melanoma with acquired imatinib resistance. J Clin Oncol. 2012 Feb 01; 30(4):e37-40.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.